{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:11:59Z","timestamp":1791000719098,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bioorg.2020.103739","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T12:24:09Z","timestamp":1583843049000},"page":"103739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors"],"prefix":"10.1016","volume":"98","author":[{"given":"Pavitra S.","family":"Thacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omkar S.","family":"Argulwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna L.","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Arifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103739_b0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic Anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.103739_b0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138161208783877884","article-title":"Carbonic Anhydrases \u2013 an overview","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2020.103739_b0015","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2020.103739_b0020","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem J."},{"key":"10.1016\/j.bioorg.2020.103739_b0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/metabo8020025","article-title":"Carbonic anhydrases and metabolism","volume":"8","author":"Supuran","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2020.103739_b0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2020.103739_b0035","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: an update","volume":"7","author":"Supuran","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/metabo8010013","article-title":"Carbonic Anhydrase IX (CAIX), cancer, and radiation responsiveness","volume":"8","author":"Ward","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2020.103739_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","article-title":"Carbonic Anhydrase functions in health and disease","volume":"623","author":"Waheed","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.bioorg.2020.103739_b0050","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/ijms17071150","article-title":"Non-classical inhibition of carbonic anhydrase","volume":"17","author":"Lomelino","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.103739_b0055","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1016\/j.bmc.2018.05.042","article-title":"Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: active role of coumarin-based structural leads in drug discovery","volume":"26","author":"Ibrar","year":"2018","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0060","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.bmc.2019.06.033","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids","volume":"27","author":"Singh","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0065","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bioorg.2019.03.003","article-title":"Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma","volume":"87","author":"Kurt","year":"2019","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0070","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bioorg.2019.02.004","article-title":"Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors","volume":"86","author":"Thacker","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejmech.2017.11.061","article-title":"Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases","volume":"143","author":"De Luca","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0080","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bmc.2016.11.039","article-title":"Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity","volume":"25","author":"Bozdag","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0085","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1016\/j.bmc.2015.09.041","article-title":"Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII","volume":"23","author":"Nocentini","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1389557514666140329200745","article-title":"[1, 2, 4]-Oxadiazoles: synthesis and biological applications","volume":"14","author":"Bora","year":"2014","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bioorg.2017.10.005","article-title":"Heterocyclic periphery in the design of carbonic anhydrase inhibitors:1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selectiveinhibitors of cytosolichCA II and membrane-boundhCA IX isoforms","volume":"76","author":"Krasavin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2018.12.049","article-title":"Continued exploration of 1,2,4-oxadiazole periphery for carbonicanhydrase-targeting primary arene sulfonamides: discovery ofsubnanomolar inhibitors of membrane-boundhCA IX isoform thatselectively kill cancer cells in hypoxic environment","volume":"164","author":"Krasavin","year":"2019","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0105","doi-asserted-by":"crossref","first-page":"102989","DOI":"10.1016\/j.bioorg.2019.102989","article-title":"Design, synthesis, in vivo, and in silico evaluation of new coumarin-1,2,4-oxadiazole hybrids as anticonvulsant agents","volume":"89","author":"Mohammadi-Khanaposhtani","year":"2019","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bioorg.2016.06.004","article-title":"Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substitutedcoumarin derivatives","volume":"67","author":"Srivastava","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0115","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.tetlet.2018.06.019","article-title":"Facile room-temperature assembly of the 1,2,4-oxadiazole core from readily available amidoximes and carboxylic acids","volume":"59","author":"Sharonova","year":"2018","journal-title":"Tet Lett."},{"key":"10.1016\/j.bioorg.2020.103739_b0120","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_h0125","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1039\/C5OB00688K","article-title":"Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"13","author":"G\u00fczel-Akdemir","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_h0130","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/cmdc.201800180","article-title":"Synthesis and biological evaluation of 4-sulfamoylphenyl\/sulfocoumarin carboxamides as selective inhibitors of carbonic anhydrase isoforms hCA II, IX, and XII","volume":"13","author":"Angapelly","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2020.103739_h0135","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1080\/14756366.2019.1626376","article-title":"Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors","volume":"34","author":"Thacker","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_h0140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/14756366.2019.1629432","article-title":"Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides ascarbonic anhydrase I, II, IV and IX inhibitors","volume":"34","author":"Swain","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103739_b0135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acsmedchemlett.8b00170","article-title":"Targeting tumor associated carbonic anhydrase IX and XII: highly isozyme selective coumarin and psoralen inhibitors","volume":"9","author":"Melis","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103739_b0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2020.103739_b0145","unstructured":"Schr\u00f6dinger Release 2018-1: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2018."},{"key":"10.1016\/j.bioorg.2020.103739_b0150","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819321649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819321649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:58:33Z","timestamp":1758614313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819321649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":32,"alternative-id":["S0045206819321649"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103739","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103739"}}